Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group-Reference-Cited by-同舟云学术

Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group

Published:2015-08-27 Issue:4 Volume:171 Page:547-556
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bröckelmann Paul J.¹²,Goergen Helen²,Fuchs Michael¹²,Kriz Jan²³,Semrau Robert²⁴,Baues Christian²⁴,Kobe Carsten²⁵,Behringer Karolin¹²,Eichenauer Dennis A.¹²,von Tresckow Bastian¹²,Klimm Beate²⁶,Halbsguth Teresa²⁷,Wongso Diana²,Plütschow Annette²,Haverkamp Heinz²,Dietlein Markus²⁵,Eich Hans T.²³,Stein Harald²⁸,Diehl Volker²,Borchmann Peter¹²,Engert Andreas¹²

Affiliation:

1. Department I of Internal Medicine; University Hospital of Cologne; Cologne Germany

2. German Hodgkin Study Group (GHSG); Cologne Germany

3. Department of Radiation Oncology; University Hospital Münster; Münster Germany

4. Department of Radiation Oncology; University Hospital of Cologne; Cologne Germany

5. Department of Nuclear Medicine; University Hospital of Cologne; Cologne Germany

6. Department III of Internal Medicine; Krankenhaus Düren; Düren Germany

7. Department II of Internal Medicine; University Hospital of Frankfurt; Frankfurt Germany

8. Pathodiagnostik Berlin; Berlin Germany

Funder

Deutsche Krebshilfe

Swiss Federal Government

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13646/fullpdf

Reference35 articles.

1. Long-term cause-specific mortality of patients treated for Hodgkin's disease;Aleman;Journal of Clinical Oncology,2003

2. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma;Barrington;European Journal of Nuclear Medicine and Molecular Imaging,2010

3. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials;Behringer;Journal of Clinical Oncology,2013

4. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial;Behringer;The Lancet,2014

5. Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS;Bijker;European Journal of Surgical Oncology,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies;Haematologica;2022-10-20

2. Laboratory Workup of Lymphoma in Adults;American Journal of Clinical Pathology;2020-11-11

3. Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists;Archives of Pathology & Laboratory Medicine;2020-11-11

4. Balancing risk and benefit in early-stage classical Hodgkin lymphoma;Blood;2018-04-12

5. Therapie des Hodgkin-Lymphoms in frühen und intermediären Stadien;Der Onkologe;2018-02-22